RXPREP Chapter 5: Compounding Flashcards

1
Q

are compounded drugs FDA approved?

A

no - they meet unique needs. the dose or formulation cannot be commercially available

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

____ sets the standards for compounding preparations

A

USP

USP 795- non sterile
USP 797- sterile
USP 800- hazardous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which 503 facility type are pharmacies that perform traditional compounding based on patient specific prescriptions?

A

503B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which 503 facility type are regulated by the state boards of pharmacy

A

503A

  • must follow USP and state board regulations
  • must register with DEA (if dispensing CS) and state board
  • compounding for MEDICAL OFFICE USE is PROHIBITED
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Section 503B allows compounding pharmacies that make sterile products for humans to register with the FDA as an ____ facility

A

outsourcing

  • can prepare meds in bulk and without a prescription written for an individual patient
  • can also compound meds for office use
  • more stringent guidelines
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

503B pharmacies must follow what regulations

A

USP and CGMPs (same standard drug manufacturers use)

  • increase product testing
  • longer BUD
  • FDA can perform inspections
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Manufacturing:

regulation:
standards:
prescription:
indentifiers:

A

regulation: FDA
standards: USP and CGMPs
prescription: not required
indentifiers: NDC numbers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
Traditional (503A) compounding:
regulation:
standards:
prescription:
indentifiers:
A

regulation: state boards
standards: USP
prescription: required
indentifiers: lot numbers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
Outsourcing (503B) compounding:
regulation:
standards:
prescription:
indentifiers:
A

regulation: FDA, state license may be required
standards: USP and CGMPs
prescription: not required
indentifiers: must have lot number, may have NDC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

ingredients that are acceptable for use will be listed in

A

USP national formulary (USP NF)

food chemicals codex (FCC)

*preferreably, ingredients should be manufactured at an FDA registered facility; if it doesn’t come from here, a certificate of analysis should be obtained to confirm quality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

all components in non sterile compounding should be stored off the floor

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

USP specifies refrigeration for what formulations only

A

water containing oral formulations only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what’s the BUD?

non sterile

does not contain water

stored at room temp

A

6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what’s the BUD?

non sterile

contains water

oral formulation

fridge

A

14 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what’s the BUD?

non sterile

contains water

non-oral formulation

room temp

A

30 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are the exceptions to the BUD recommendations?

A
  • if any ingredients deteriorates easily, select shorter BUD
  • if any ingredient expires before the BUD, use earlier date
  • BUDs can be extended if stability data is obtained that determines the drug is stable for longer period
17
Q

USP 797 formulations

A

IV, IM, SC, SQ, eye drops, inhalations, irrigations

18
Q

in critical areas that are closest to exposed sterile drugs and containers, the air must be at least

A

ISO 5

19
Q

The buffer area (SEC) must be at least ISO

A

ISO 7

20
Q

the anteroom must be at least ISO8 if

A

if it opens into a positive pressure buffer area (non-haz)

or at least 7 if it opens to a negative pressure buffer area (hazardous sterile)

21
Q

CSP risk level?

<3 sterile ingredients, no more than 2 entries into any 1 sterile container or device

A

low

22
Q

CSP risk level?

> 3 sterile ingredients OR multiple doses of a sterile product withdrawn from the same vial to make several CSPs of the same product (a batch)

A

medium

TRN

23
Q

CSP risk level?

non sterile ingredients and equipment

A

high

24
Q

The default BUD is determined by…

A

the CSP risk level and the storage temperature

25
Q

CSP risk level: low
room temperature
BUD:

A

CSP risk level:
room temperature
BUD:48 hours

26
Q

CSP risk level: medium
room temperature
BUD:

A

CSP risk level:
room temperature
BUD: 30 hours

27
Q

CSP risk level: high
room temperature
BUD:

A

CSP risk level:
room temperature
BUD: 24 hours

28
Q

CSP risk level: low
fridge
BUD:

A

CSP risk level:
fridge
BUD: 14 days

29
Q

CSP risk level: medium
fridge
BUD:

A

CSP risk level:
fridge
BUD: 9 days

30
Q

CSP risk level: high
fridge
BUD:

A

CSP risk level:
fridge
BUD: 3 days

31
Q

CSP risk level: any
frozen
BUD:

A

45 days

32
Q

low risk compounds prepared in an ISO 5 PEC in an SCA receives what BUD

A

12 hour; whether its stored in fridge or room temp

33
Q

immediate use CSPs BUD

A

one hour

34
Q

how often should the hazardous list be reviewed?

A

every 12 months

35
Q

the C-SEC must maintain ISO

A

7

C SEC can contain both sterile and non sterile C PECs

must be one meter apart

36
Q

assessment of risk documents must be reviewed at least every __ months

A

12

37
Q

how should HD drugs be stored?

A

NOT on the floor

separately from non HD drugs

negative pressure room with external ventilation and at least 12ACPH

38
Q

pharmacies involved in HD compounding must perform wipe sampling of all compounding surfaces initially and every __ months

A

6 months

39
Q

if the drug being repackaged is an FDA approved drug, USP and FDA guidance assigns a BUD of ___ months from the date of repackaging

A

6